… host cells will help us understand SARS-CoV-2-induced lung … obtained from the lungs of
deceased COVID-19 patients, we … hints about host cell metabolic alterations in COVID-19, and …

… pathological analyses of COVID-19 decedents should … the lungs and lymphatic organs of
12 COVID-19 decedents—… cell signature and inflammatory factor expression in the lungs, …

… a negative correlation between the number of memory B cells and COVID-19 symptom
duration [33]; the number of these cells correlated with IgG1 and IgM against the SARS-CoV‑2 …

… Furthermore, in non-small cell lung cancer cell lines, estradiol increases the expression
levels and activity of ADAM17 [41]. This last finding would suggest higher shedding of ACE2 in …

… in leukocytes, within the lungs of all patients with fatal COVID-19 in the areas of lung injury.
The … higher in the lungs of patients with fatal COVID-19 as compared with the lungs of control …

… of coronavirus disease (COVID-19) and control autopsy lungs. (… syndrome coronavirus 2
(SARS-CoV-2)– infected (COVID-19) … cells recovered by BAL from patients with COVID-19 lung …

… Some authors point to pronounced squamous cell metaplasia in COVID-19 [7, 22, 31, 35],
which is most likely associated with direct viral damage to the epithelium, as well as with …

… lung disorders including fibrosis. The findings of this study propose the hypotheses that
lung-… antiviral drugs such as remdesivir to further improve COVID-19 outcomes in the elderly. …

… COVID-19 mainly causes damage to the lung, as well as other … stem cell therapy in COVID-19,
and registered COVID-19 clinical trials. Of all the stem cell therapies touted for COVID-19 …

… coronavirus-2 (SARS-CoV-2), responsible for the widespread clinical syndrome known as
coronavirus disease 2019 (COVID-19). … cells and vascular endothelial cells, as well as to lung …